KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Short-term Investments (2020 - 2025)

Neogenomics' Short-term Investments history spans 6 years, with the latest figure at $9.0 million for Q2 2025.

  • For Q2 2025, Short-term Investments fell 72.65% year-over-year to $9.0 million; the TTM value through Jun 2025 reached $9.0 million, down 72.65%, while the annual FY2024 figure was $19.8 million, 72.73% down from the prior year.
  • Short-term Investments reached $9.0 million in Q2 2025 per NEO's latest filing, down from $11.9 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $203.0 million in Q2 2021 to a low of $9.0 million in Q2 2025.
  • Average Short-term Investments over 5 years is $116.0 million, with a median of $131.3 million recorded in 2023.
  • Peak YoY movement for Short-term Investments: skyrocketed 301.28% in 2021, then crashed 77.54% in 2025.
  • A 5-year view of Short-term Investments shows it stood at $198.6 million in 2021, then dropped by 11.96% to $174.8 million in 2022, then tumbled by 58.4% to $72.7 million in 2023, then crashed by 72.73% to $19.8 million in 2024, then tumbled by 54.81% to $9.0 million in 2025.
  • Per Business Quant, the three most recent readings for NEO's Short-term Investments are $9.0 million (Q2 2025), $11.9 million (Q1 2025), and $19.8 million (Q4 2024).